Regulatory Roundup: EMA and the European Monitoring Center for Drugs to Cooperate; And More. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: EMA and the European Monitoring Center for Drugs to Cooperate; And More.

ePT--the Electronic Newsletter of Pharmaceutical Technology

The European Medicines Agency (EMA) and the European Monitoring Centre for Drugs and Drug Addiction agreed to a working arrangment on June 14, 2010, as part of EMA’s initiative to “cooperate with other European Union bodies for early identification and management of potential conflicts over scientific opinions,” according to an agency press release. The agreement includes fostering cooperation between the two agencies, including sharing information and reports on new psychoactive substances and any misuse of these products.

 

According to various Chinese media reports, on June 13, 2010, the deputy head of the China State Food and Drug Administration (SFDA), Zhang Jingli, was fired for disciplinary violations. In 2007, the then SFDA Chief Zheng Xiaoyu was executed after an investigation showed that he approved unsafe drugs, which ultimately led to the deaths of some consumers, in exchange for money. An investigation on Zhang is being conducted.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here